Globus Medical GMED Payments for Repurchase of Common Stock
Payments for Repurchase of Common Stock at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.
The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's payments for repurchase of common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Globus Medical's payments for repurchase of common stock?
- Globus Medical (GMED) reported payments for repurchase of common stock of $0 in Q1 2026.
- How has Globus Medical's payments for repurchase of common stock changed year-over-year?
- Globus Medical's payments for repurchase of common stock decreased by 100.0% year-over-year, from $190.45M to $0.
- What is the long-term trend for Globus Medical's payments for repurchase of common stock?
- Over 3 years (2022 to 2025), Globus Medical's payments for repurchase of common stock has grown at a 27.6% compound annual growth rate (CAGR), from $144.49M to $300.45M.